The global vaccines market is expected to witness substantial growth through 2036, driven by increasing awareness regarding preventive healthcare, rising prevalence of infectious diseases, and continuous advancements in vaccine technologies. Governments, healthcare organizations, and pharmaceutical companies are investing heavily in vaccine research, manufacturing, and immunization programs to strengthen public health systems worldwide.

According to industry analysis, the global vaccines market was valued at US$ 73.4 billion in 2025 and is projected to reach US$ 135.7 billion by 2036, expanding at a CAGR of 5.7% from 2026 to 2036. The market’s growth is being fueled by increasing demand for routine immunization, rising adoption of next-generation vaccines, and the growing focus on pandemic preparedness.

👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85668

Rising Demand for Preventive Healthcare Driving Market Growth

Vaccination has become one of the most effective tools for preventing infectious diseases and reducing healthcare burdens globally. Increasing awareness regarding immunization benefits and rising government-led vaccination campaigns are supporting the growth of the vaccines market.

The growing incidence of diseases such as influenza, COVID-19, hepatitis, pneumococcal infections, and HPV-related conditions is encouraging healthcare systems to strengthen immunization programs. In addition, expanding vaccination coverage in emerging economies is creating significant opportunities for vaccine manufacturers.

Technological Advancements Transforming Vaccine Development

Technological innovation is playing a major role in shaping the vaccines market. The success of mRNA vaccines during the COVID-19 pandemic accelerated investments in advanced vaccine platforms, including recombinant, protein-based, viral vector, and DNA-based vaccines.

Pharmaceutical companies are focusing on improving vaccine efficacy, safety, and storage capabilities while reducing production timelines. Artificial intelligence, genomic sequencing, and advanced bioprocessing technologies are also helping accelerate vaccine discovery and development.

The emergence of personalized vaccines and therapeutic vaccines for cancer and chronic diseases is expected to open new growth avenues for the industry.

Injectable Vaccines Continue to Dominate

By route of administration, the injectable segment accounted for the largest market share of 81.0% in 2025. Injectable vaccines remain the preferred option due to their proven effectiveness, rapid immune response, and widespread adoption in routine immunization programs.

However, oral and intranasal vaccines are also gaining attention as companies focus on improving patient convenience and vaccine accessibility. These alternative delivery methods are expected to support future market diversification.

North America Leads Global Market

North America dominated the global vaccines market in 2025, accounting for the largest revenue share of 39.4%. The region benefits from advanced healthcare infrastructure, strong government support for immunization programs, and the presence of leading pharmaceutical and biotechnology companies.

The U.S. continues to remain a key innovation hub for vaccine development, supported by significant investments in research and development activities. High awareness regarding preventive healthcare and strong adoption of seasonal vaccination programs are also contributing to regional market growth.

Meanwhile, Asia Pacific is expected to witness significant expansion during the forecast period due to increasing healthcare expenditure, growing population, and expanding vaccination initiatives in countries such as India and China.

👉 Discuss Implications for Your Industry or Do you want customize Report, Please Request Sample Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85668

Competitive Landscape: Companies Focus on Innovation and Strategic Partnerships

The vaccines market is highly competitive, with major pharmaceutical companies focusing on strategic collaborations, advanced research, and portfolio expansion to strengthen their market presence.

Key players operating in the market include Serum Institute of India Pvt. Ltd., Seqirus, Sanofi, Merck & Co., Inc., Pfizer Inc., Moderna Inc., Sinovac, BioNTech SE, AstraZeneca, GSK, Panacea Biotec, EMERGENT, CSL, and Bavarian Nordic.

These companies are focusing on expanding manufacturing capabilities, accelerating vaccine approvals, and investing in advanced technologies to meet growing global demand.

Recent Developments Strengthening the Market

Several recent product approvals and launches are shaping the future of the vaccines market.

• In August 2025, Moderna Inc. received U.S. FDA approval for its updated 2025-2026 COVID-19 vaccine formulations, including Spikevax and mNexspike, designed to target current SARS-CoV-2 variants and support seasonal immunization programs.

During the same period, Pfizer Inc. and BioNTech SE secured U.S. FDA approval for the updated Comirnaty COVID-19 vaccine formulation for the 2025-2026 vaccination season.

• In August 2025, Novavax received approval in the U.S. for Nuvaxovid, a protein-based COVID-19 vaccine intended for the 2025-2026 immunization period.

Additionally, in November 2025, Zoetis launched Vanguard Recombishield, a recombinant injectable vaccine for dogs designed to protect against kennel cough caused by Bordetella bronchiseptica. The vaccine was licensed by the USDA and features pertactin protein technology to enhance immune response.

Emerging Opportunities in Adult and Therapeutic Vaccination

The vaccines market is also witnessing increasing demand for adult immunization and therapeutic vaccines. Aging populations and rising awareness regarding preventive healthcare are encouraging governments to expand adult vaccination programs against influenza, shingles, pneumococcal disease, and respiratory infections.

Therapeutic vaccines targeting cancer and chronic diseases are also gaining momentum, supported by advancements in immunotherapy and precision medicine. These innovations are expected to significantly reshape the future of the vaccines industry.

Future Outlook: Innovation and Global Immunization to Drive Growth

The future of the global vaccines market appears highly promising, supported by technological advancements, increasing healthcare investments, and growing emphasis on global immunization coverage. The integration of AI-driven drug discovery, genomic technologies, and personalized medicine is expected to accelerate vaccine innovation in the coming years.

Companies focusing on advanced vaccine platforms, strategic partnerships, and scalable manufacturing capabilities are likely to maintain a strong competitive advantage in the evolving market landscape.

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=85668&ltype=S

In conclusion, the global vaccines market is poised for strong long-term growth, projected to reach US$ 135.7 billion by 2036. Rising demand for preventive healthcare, continuous innovation in vaccine technologies, and expanding immunization initiatives worldwide will continue to drive the market’s expansion across both human and veterinary healthcare sectors.

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Media Contact:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453